enter / eng /

Materials and Analytical Facilities

CRISP – Cluster of Research Infrastructures for Synergies in Physics


 Dr. Michael Krisch



CRISP allows RIs to strengthen their role in the advancement of knowledge and sti­mulates scientific and technological progress. CRISP activities are of enormous be­nefit to large scale facilities – such as national light and x-ray sources, high-energy and nuclear facilities - in the European Research Area and beyond. The objective of the eleven participating Research Infrastructures (RIs) is to build up collaborations and to create long-term synergies to facilitate their implementation and enhance their efficiency and attractive­ness. The CRISP project focuses on four areas: (i) Accelerators, (ii) Instruments & Experiments, (iii) Detectors & Data Acquisition, and (iv) Information Technology & Data Management. The exchange of know-how, together with the combined complementary expertise of CRISP members, ensures cost-efficient and coherent scientific progress.


EMFL – European Magnetic Field Laboratory


 Dr. Mr. van Breukelen



The mission of the European Magnetic Field Laboratory (EMFL) is to develop and operate world class high magnetic field facilities and to use them for excellent re­search by in-house and external users. EMFL consists of four sites; Dresden (DE), Grenoble (FR), Nijmegen (NL) and Toulouse (FR) all possessing a large infrastruc­ture to generate the highest fields with the most powerful magnets and equipped to do a wide variety of advanced experiments with them. EMFL will manage the scientific access of its users to its installations, the selection of the proposals being made by an independent external selection committee. EMFL has been granted a 3-year EU Preparation Phase Project (2011-2013) and is now in the process of being founded as an AISBL legal entity, to formalise the already far going cooperation between the four sites. EMFL will allow Europe to take the lead in the production and use of very high magnetic fields for scientific goals and face the global competition.





 Dr. Michael Krisch



The European Synchrotron Radiation Facility is funded and shared by 19 countries and brings together a wide range of disciplines including physics, chemistry and materials science, biology, medicine, environment and archaeology. With some 6400 scientific user visits each year, resulting in more than 1800 refereed publications, the ESRF is recognised as the world’s number one synchrotron light source. In order to maintain its leading role and to respond to emerging scientific challenges, the ESRF has been implementing since 2009 an ambitious ten-year Upgrade Programme, comprising (i) the construction of new and upgraded beamlines with unique performances, ensuring new scientific opportunities, (ii) major improvements of the accelerator com­plex, (iii) the development of productive science and technology driven partnerships with academic institutes and industrial partners, and (iv) the extension of the experimental hall to ensure the thermal and vibrational stability needed by the new beamlines.



EUMINAfab – Integrating European research infrastructures for micro-nano fabrication



 Dr. Susan Anson



»EUMINAfab – Open access to European nano and micro centres

Nano and Microsystems technologies are widely accepted to have key relevance for a broad range of application areas. EUMINAfab is a European Research Infrastructure focusing on multimateral micro- and nanofabrication and characterization techno­logies. Innovative ideas employing solutions using these techniques require not only access to high end equipment but also the essential highly skilled personnel. The coordination of the facilities available at EUMINAfab’s specia­list European partner sites leverages this innovation potential for the wider community. The environment of open innovation allows not only no-fee access to the technologies but also the necessary technology expertise and advice required to transform the innovative ideas of our users into reality. The FP7 Capacities funding enables us to accommodate users from academia and industry on a no fee basis for public research. The aim is to facilitate the use of high end nano and micro technologies to enable next generation products.




EuroFEL – Free electron lasers of Europe


 Dr. Josef Feldhaus



»IRUVX-PP: The preparatory phase of EuroFEL

The IRUVX-PP project (April 2008 to March 2011) has prepared the creation of the EuroFEL consortium (previously called IRUVX-FEL) of national free electron laser (FEL) light sources as a unique, distributed European research infrastructure provi­ding world-class instruments and service for novel and wide-ranging studies of mat­ter by a multi-disciplinary science community. Its ensemble of light sources will complement present synchrotron radiation sources and conventional lasers. FELs are the flash cameras for the molecular world, adding the femto­second time scale to nanometer microscopy for observing e.g. the fundamental processes governing all chemical phenomena. Scientific challenges and opportunities will open for a wide range of scientific disciplines, ranging from the physics of atoms, molecules and clusters to plasma physics, chemistry, materials and life sciences.



FRM II – Forschungs-Neutronenquelle Heinz Maier-Leibnitz


 Dr. Jürgen Neuhaus



»FRM II: Neutrons for Research, Industry and Medicine

The Technische Universität München (TUM) operates the neutron source Heinz Mai­er-Leibnitz in Garching, Germany. The scientific use is managed by a consortium of the TUM and centers of the Helmholtz association in Jülich (FZJ), Geesthacht (HZG) and Berlin (HZB). The neutron source acts as a service facility for national and inter­national scientists. Applications for beam time are peer reviewed by international committees twice a year. Funded as a national, German facility, European users are supported by an Integrated Infrastructure Initiative NMI3, fun­ded up to now through FP6 and FP7. About 40% of the available beam time is attracted by international research teams. In addition to basic research a special focus is on industrial and medical usage of the FRM II. Whereas the irradiation facility for transmutation doping of Si plays the most important role for industrial applications, radioi­sotope production and direct treatment of patients with fast neurons cover the medical usage.




QNano – A pan-European infrastructure for quality in nanomaterials safety testing


 Dr. Sergio Anguissola


| www.qnano-ri.eu

QNano is a research infrastructure for characterisation of nanomaterials for safety assessment, funded through the FP7 Capacities programme. QNano is creating a neutral space for nanosafety evaluations shaped by best practice and mutually re­cognised round-robin validated methodology. QNano has created an integrated fra­mework for funded access to leading facilities for nanomaterials synthesis and characterisation facilities and provides an extensive range of support services for users and stakeholders. Access is via 6-monthly calls an­nounced on the QNano website: www.qnano-ri.eu. Dynamic networking activities are conducted through a series of hubs, including one fostering excellence in knowledge transfer for safety assessment and another focusing on development and provision of positive and negative control nanomaterials for selected biological endpoints. Partners in QNano are conducting research activities including refining current approaches for the reduction in variability between nanomaterial batches, developing reliable labeling techniques and proposing new methods for identification and characterisation of nanomaterials in situ.

Developed in MCG
2011, Bogolyubov Institute for Theorethical Physics